EDIT Neil O'Neill Gilmore sold Editas Medicine, Inc. shares — SEC Form 4SELLEditas Medicine, Inc.

Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 6,486 shares at $9.50 ($62K) on 2023-06-05, disclosed to the SEC on 2023-06-07.

SEC EDGAR Filing

0001415889-23-009369

View on SEC EDGAR

Trade context

Scheduled sale ($62k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest52/100

Nothing distinguishes this filing.

Opportunistic Sell

Trade Context

•Decreased holdings by 5%
•3rd largest sale, out of 12
•Part of a 10b5-1 trading plan

Filing Info

Filed2023-06-07

Traded2023-06-05

Accession0001415889-23-009369

SourceSEC EDGAR (Historical)

Insider

NameNeil O'Neill Gilmore

TitleCEO

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
EDIT	SELL	2026-09-04	$16K	—	Filing →
EDIT	SELL	2026-06-05	$42K	—

Get an email when an insider at EDIT files

Free account. Follow EDIT and up to 10 more companies.

Follow EDIT for free

EDIT Neil O'Neill Gilmore sold Editas Medicine, Inc. shares — SEC Form 4SELLEditas Medicine, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes